Should safety of the flu vaccine for cancer patients be reexamined? [version 1; peer review: 2 approved with reservations]

Slobodan Paessler, Veljko Veljkovic

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Seasonal flu vaccine is recommended as the best protection for cancer patients against influenza infection. Recent in silico and experimental data suggest that antibodies elicited with influenza vaccine could activate bradykinin receptor B2-associated signaling pathway, which is also involved in cell proliferation and migration of tumor cells. These results point to an urgent need for the reexamination of safety of influenza vaccine(s) in cancer patients.

Original languageEnglish (US)
Article number1
JournalF1000Research
Volume7
DOIs
StatePublished - 2018

Keywords

  • Breast cancer
  • Influenza
  • Vaccine

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Should safety of the flu vaccine for cancer patients be reexamined? [version 1; peer review: 2 approved with reservations]'. Together they form a unique fingerprint.

  • Cite this